Current Trends in Pharmacy and Pharmaceutical Chemistry

Online ISSN: 2582-5062

Current Trends in Pharmacy and Pharmaceutical Chemistry is the official Journal of Ateos Foundation of Science Education and Research, hosted and Managed IP Innovative Publications Pvt. Ltd, New Delhi, India. Current Trends in Pharmacy and Pharmaceutical Chemistry is an open access, peer-reviewed quarterly international journal publishing since 2019 and is published under auspices of the Ateos Foundation of Science Education and Research. It aims to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. more...

Article type

Original Article


Article page

30-31


Authors Details

Jaydip Vaishnav*


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 280

PDF Downloaded: 148


Synthesis of 2,6-dichloro-benzamides for evaluation antimicrobial and disinfectant activity: Part-I


Original Article

Author Details : Jaydip Vaishnav*

Volume : 6, Issue : 1, Year : 2024

Article Page : 30-31

https://doi.org/10.18231/j.ctppc.2024.007



Suggest article by email

Get Permission

Abstract

2,6-dichlorobenzamide derivatives have been synthesized and claimed in this research study. The compound JV1 and JV2 were synthesized by known methods. Ethylene diamine and isopropyl amine was dissolved in ethanolic 1 N NaOH separately and to it 2,6-dichlorobenzoyl chloride was added. The products JV1 and JV2 were collected respectively.


Keywords: Benzamide, Ethylene diamine, Iso­propylamine, Antimicrobial and Disinfectant


How to cite : Vaishnav J, Synthesis of 2,6-dichloro-benzamides for evaluation antimicrobial and disinfectant activity: Part-I. Curr Trends Pharm Pharm Chem 2024;6(1):30-31

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.